首页> 美国卫生研究院文献>Molecular Therapy >A Lentiviral Fluorescent Genetic Barcoding System for Flow Cytometry-Based Multiplex Tracking
【2h】

A Lentiviral Fluorescent Genetic Barcoding System for Flow Cytometry-Based Multiplex Tracking

机译:基于流式细胞术的多重跟踪的慢病毒荧光遗传条形码系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Retroviral integration site analysis and barcoding have been instrumental for multiplex clonal fate mapping, although their use imposes an inherent delay between sample acquisition and data analysis. Monitoring of multiple cell populations in real time would be advantageous, but multiplex assays compatible with flow cytometric tracking of competitive growth behavior are currently limited. We here describe the development and initial validation of three generations of lentiviral fluorescent genetic barcoding (FGB) systems that allow the creation of 26, 14, or 6 unique labels. Color-coded populations could be tracked in multiplex in vitro assays for up to 28 days by flow cytometry using all three vector systems. Those involving lower levels of multiplexing eased color-code generation and the reliability of vector expression and enabled functional in vitro and in vivo studies. In proof-of-principle experiments, FGB vectors facilitated in vitro multiplex screening of microRNA (miRNA)-induced growth advantages, as well as the in vivo recovery of color-coded progeny of murine and human hematopoietic stem cells. This novel series of FGB vectors provides new tools for assessing comparative growth properties in in vitro and in vivo multiplexing experiments, while simultaneously allowing for a reduction in sample numbers by up to 26-fold.
机译:逆转录病毒整合位点分析和条形码已经为多重克隆命运定位提供了工具,尽管它们的使用在样品采集和数据分析之间存在固有的延迟。实时监测多个细胞群将是有利的,但是与流式细胞术跟踪竞争性生长行为兼容的多重测定法目前受到限制。我们在这里描述了三代慢病毒荧光遗传条形码(FGB)系统的开发和初步验证,这些系统允许创建26、14或6个唯一标签。使用所有三种载体系统,通过流式细胞术,可以在体外测定中以多路追踪颜色编码的种群长达28天。那些涉及较低水平多路复用的方法简化了颜色代码的生成和载体表达的可靠性,并在体外和体内研究中发挥了作用。在原理验证实验中,FGB载体促进了microRNA(miRNA)诱导的生长优势的体外多重筛选,以及小鼠和人类造血干细胞颜色编码后代的体内回收。这种新颖的FGB载体系列为评估体外和体内多路复用实验中的相对生长特性提供了新的工具,同时允许将样品数量减少多达26倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号